Oil prices will mount a recovery
Hopes of a Covid-19 vaccine lifted oil markets earlier this week, with Brent crude jumping to $43 a barrel.
Hopes of a vaccine lifted oil markets earlier this week, with Brent crude jumping to $43 a barrel. Bulls were also cheered by the Saudi energy minister, who suggested that the so-called Opec+ output deal could be in for a “tweak”. The current deal sees major oil producers such as Russia and Saudi Arabia hold output 7.7 million barrels per day (mbpd) below 2018 levels. That figure is due to fall to 5.7mbpd in January, but the latest wave of lockdowns will hit global demand, prompting speculation that the output curbs could be extended deep into next year. Global crude oil demand was roughly 100mbpd last year, but the pandemic has reduced the world’s appetite for the fuel by about 10%.
The oil outlook remains shaky, says Julian Lee on Bloomberg. The demand slump extends even to places that have dealt with the virus well: Japanese imports from the main Persian Gulf producers are still down by half compared with pre-pandemic levels. On the supply side, US output is proving robust. America is China’s third biggest oil-supplier after Russia and Saudi Arabia. The second wave of lockdowns will hold oil markets “in check” over the coming months, says Stephen Innes of Axi. But the prospect of a vaccine is a “game-changer for the oil complex”. With Opec+ signalling that it is ready to do “whatever it takes” to support prices, oil prices have two “planks” to rest on while they wait out the winter.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
![https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748-320-80.jpg)
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
Regulator moves to protect access to cash amid branch closures and disappearing ATMs
News The Financial Conduct Authority has told banks to start assessing if local communities have adequate cash access from mid-September
By Marc Shoffman Published
-
VAT hike on private school fees could come earlier than previously expected
The government could start charging VAT on private school fees as soon as January 2025, according to the latest reports. What does it mean for parents?
By Katie Williams Published
-
UK mid-caps: an improving outlook
UK mid-caps have perked up and the rally may run further, but long-term investors should remain selective
By Cris Sholto Heaton Published
-
The tobacco industry is going smoke-free - how to profit from it
Tobacco companies have realised their traditional products are on the wane. But new opportunities have opened up – and should prove lucrative
By Rupert Hargreaves Published
-
Is it time to invest in creative industries?
Any industrial strategy should not overlook the creative industries, one of our top national assets
By David C. Stevenson Published
-
Is Mercia Asset Management set for success?
Mercia Asset Management helps the government fund smaller companies in Britain’s regions. Should you invest?
By Rupert Hargreaves Published
-
British stocks set for a boost
British stocks are due for a bounce as the UK looks more stable compared to many economies
By Alex Rankine Published
-
Ocado shares jump by a fifth
Ocado takes a turn for the better after attractive profit forecasts were announced
By Dr Matthew Partridge Published
-
The AI boom is on borrowed time
The hype around the AI boom could be on its way out – but why?
By Alex Rankine Published
-
Diploma: a blue-chip set for strong growth
Diploma, whose niche products include seals and fasteners, serves an array of growth markets. Should you invest?
By Dr Mike Tubbs Published